Literature DB >> 9887211

Sample preparation for peptide mapping--A pharmaceutical quality-control perspective.

N Lundell1, T Schreitmüller.   

Abstract

In quality control of therapeutic proteins peptide mapping is used for confirmation of primary structure and detection of posttranslational modifications. The demands put on the experimental procedure are therefore different than in the case of determination of an unknown protein structure. It is here recognized that a peptide-mapping method for quality control of proteins should be inert (not induce or revert modifications), general, robust, and allow a high sample throughput. The steps prior to the separation of the generated peptides are identified as crucial for meeting these demands. This includes denaturation, reduction, alkylation, buffer exchange, solubilization, and digestion. A critical review of the literature regarding these steps is presented. Relevant options in all steps are experimentally evaluated. Novel approaches are developed for many of the steps. The result is a sample preparation procedure that essentially meets the stated demands. Copyright 1999 Academic Press.

Mesh:

Substances:

Year:  1999        PMID: 9887211     DOI: 10.1006/abio.1998.2919

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  17 in total

1.  Classification of lactate dehydrogenase of different origin by liquid chromatography-mass spectrometry and multivariate analysis.

Authors:  Dan Bylund; Jenny Samskog; Karin E Markides; Sven P Jacobsson
Journal:  J Am Soc Mass Spectrom       Date:  2003-03       Impact factor: 3.109

2.  Optimization of mass spectrometry-compatible surfactants for shotgun proteomics.

Authors:  Emily I Chen; Daniel Cociorva; Jeremy L Norris; John R Yates
Journal:  J Proteome Res       Date:  2007-05-27       Impact factor: 4.466

3.  Effects of modified digestion schemes on the identification of proteins from complex mixtures.

Authors:  Aaron A Klammer; Michael J MacCoss
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

4.  Deciphering the Biophysical Effects of Oxidizing Sulfur-Containing Amino Acids in Interferon-beta-1a using MS and HDX-MS.

Authors:  Damian J Houde; George M Bou-Assaf; Steven A Berkowitz
Journal:  J Am Soc Mass Spectrom       Date:  2017-02-13       Impact factor: 3.109

5.  Selective Gas-Phase Oxidation and Localization of Alkylated Cysteine Residues in Polypeptide Ions via Ion/Ion Chemistry.

Authors:  Alice L Pilo; Feifei Zhao; Scott A McLuckey
Journal:  J Proteome Res       Date:  2016-08-18       Impact factor: 4.466

6.  A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy.

Authors:  Richard S Rogers; Michael Abernathy; Douglas D Richardson; Jason C Rouse; Justin B Sperry; Patrick Swann; Jette Wypych; Christopher Yu; Li Zang; Rohini Deshpande
Journal:  AAPS J       Date:  2017-11-30       Impact factor: 4.009

7.  Stable and Potent Selenomab-Drug Conjugates.

Authors:  Xiuling Li; Christopher G Nelson; Rajesh R Nair; Lori Hazlehurst; Tina Moroni; Pablo Martinez-Acedo; Alex R Nanna; David Hymel; Terrence R Burke; Christoph Rader
Journal:  Cell Chem Biol       Date:  2017-03-16       Impact factor: 8.116

8.  Metal-catalyzed oxidation of brain-derived neurotrophic factor (BDNF): analytical challenges for the identification of modified sites.

Authors:  J L Jensen; C Kolvenbach; S Roy; C Schöneich
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

9.  Top-Down Characterization of an Intact Monoclonal Antibody Using Activated Ion Electron Transfer Dissociation.

Authors:  Jean M Lodge; Kevin L Schauer; Dain R Brademan; Nicholas M Riley; Evgenia Shishkova; Michael S Westphall; Joshua J Coon
Journal:  Anal Chem       Date:  2020-07-16       Impact factor: 6.986

10.  SP3-FAIMS Chemoproteomics for High-Coverage Profiling of the Human Cysteinome*.

Authors:  Tianyang Yan; Heta S Desai; Lisa M Boatner; Stephanie L Yen; Jian Cao; Maria F Palafox; Yasaman Jami-Alahmadi; Keriann M Backus
Journal:  Chembiochem       Date:  2021-02-18       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.